Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Predicting Response to ITB, VDR, and DBS in Children With Dystonic Cerebral Palsy
NCT06606574Recruiting
- Sponsor
- Baylor College of Medicine
- Start
- Nov 2024
- Primary completion
- Jun 2029
- Countries
- 1
01
Overview
Open-label trial of baclofen in dystonic cerebral palsy (3 arms), sponsored by Baylor College of Medicine. Primary endpoint: Barry-Albright Dystonia Scale at 52 weeks. Started Nov 2024; status: recruiting.
02
Drugs
baclofen
03
Conditions
dystonic cerebral palsy
Beyond the preview
Go deeper on NCT06606574.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06606574.